HEALTH TOPICS 
New drug fizzles at raising HDL
With the failure of torcetrapib, a drug that its maker hoped
would raise HDL cholesterol, people seeking to lower their heart
disease risk should rely on traditional strategies: exercise,
diet, weight control.
To continue reading this article, you must login.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise